Edition:
United Kingdom

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

5.61USD
23 Aug 2019
Change (% chg)

$-0.10 (-1.75%)
Prev Close
$5.71
Open
$5.70
Day's High
$5.78
Day's Low
$5.58
Volume
557,634
Avg. Vol
386,825
52-wk High
$7.84
52-wk Low
$3.90

Latest Key Developments (Source: Significant Developments)

Pacific Biosciences Of California Reports Qtrly Loss Per Share $0.20
Friday, 3 May 2019 

May 3 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS.GIVEN PENDING MERGER WITH ILLUMINA, WILL NOT BE HOSTING CONFERENCE CALL TO DISCUSS ITS RESULTS FOR Q1.QTRLY LOSS PER SHARE $0.20.Q1 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA.QTRLY TOTAL REVENUE $16.4 MILLION VERSUS $19.4 MILLION.Q1 REVENUE VIEW $21.6 MILLION -- REFINITIV IBES DATA.PACIFIC BIOSCIENCES OF CALIFORNIA - GIVEN PENDING MERGER WITH ILLUMINA, ALSO DOES NOT EXPECT TO HOST CONF CALL TO DISCUSS ITS RESULTS FOR FUTURE QUARTERS.  Full Article

Oxford Nanopore Prevails Against PacBio In Final Decision By U.S. Court Of Appeal
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Oxford Nanopore::OXFORD NANOPORE - U.S. COURT OF APPEALS FOR FEDERAL CIRCUIT TODAY UPHELD DECISION OF INTERNATIONAL TRADE COMMISSION (ITC) IN FAVOUR OF OXFORD NANOPORE.  Full Article

Pacific Biosciences Of California Q2 Loss Per Share $0.17
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 REVENUE $21.6 MILLION VERSUS I/B/E/S VIEW $23.8 MILLION.QTRLY LOSS PER SHARE $0.17.PACIFIC BIOSCIENCES OF CALIFORNIA - CASH, CASH EQUIVALENTS AND INVESTMENTS, AT JUNE 30, 2018 TOTALED $63.5 MILLION, VERSUS $62.9 MILLION AT DECEMBER 31, 2017.  Full Article

Pacific Biosciences Of California reports Q3 revenue $23.5 mln
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Pacific Biosciences Of California Inc :Pacific Biosciences Of California Inc announces third quarter 2017 financial results.Q3 revenue $23.5 million versus I/B/E/S view $28.5 million.Pacific Biosciences Of California Inc - ‍net loss for q3 of 2017 was $22.0 million, compared to $17.5 million for q3 of 2016​.Pacific Biosciences Of California Inc qtrly loss per share $‍0.19​.  Full Article

Photo

Exclusive: Woodford biotech stakes first off block in asset sale - source

LONDON/FRANKFURT British fund manager Neil Woodford is looking to kick off the sale of his unlisted biotech investments at the end of July, but faces months of negotiations to offload the portfolio, a source familiar with the matter told Reuters.